Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$1.61B |
| 2 |
Abbott
ABT
|
+$1.02B |
| 3 |
British American Tobacco
BTI
|
+$1B |
| 4 |
GE Aerospace
GE
|
+$961M |
| 5 |
AbbVie
ABBV
|
+$818M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61B |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$1.97B |
| 3 |
VALE.P
Vale S A
VALE.P
|
+$1.39B |
| 4 |
Texas Instruments
TXN
|
+$1.02B |
| 5 |
Boeing
BA
|
+$981M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.18% |
| 2 | Technology | 15.85% |
| 3 | Consumer Discretionary | 11.67% |
| 4 | Financials | 11.33% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEE.PRR
226
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $199M | 0.06% |
3,600,000
| – | – |
|
227
Tesla
TSLA
$1.29T
| $198M | 0.06% |
8,701,500
-675,000
| -7% | -$15.6M |
|
228
Jefferies Financial Group
JEF
$12.6B
| $197M | 0.06% |
8,717,276
| – | – |
|
229
Petrobras Class A
PBR.A
$103B
| $196M | 0.06% |
20,288,169
+4,664,330
| +30% | +$40.6M |
|
|
DCUD
230
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $196M | 0.06% |
3,855,302
| – | – |
|
231
Novartis
NVS
$290B
| $194M | 0.06% |
2,520,503
+11
| +0% | +$831 |
|
232
Occidental Petroleum
OXY
$58.5B
| $193M | 0.06% |
3,000,000
| – | – |
|
233
BWX Technologies
BWXT
$15.8B
| $190M | 0.06% |
3,399,163
-65,099
| -2% | -$3.45M |
|
234
Texas Capital Bancshares
TCBI
$4.38B
| $189M | 0.06% |
2,201,895
+74,000
| +3% | +$5.75M |
|
235
Cedar Fair
FUN
$1.68B
| $187M | 0.06% |
2,923,500
| – | – |
|
|
MGP
236
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $182M | 0.05% |
6,018,749
+700,000
| +13% | +$21M |
|
237
Hilton Grand Vacations
HGV
$3.49B
| $181M | 0.05% |
4,678,200
| – | – |
|
238
KeyCorp
KEY
$24.5B
| $178M | 0.05% |
9,456,501
-5,368,651
| -36% | -$97.1M |
|
239
Williams Companies
WMB
$90.1B
| $177M | 0.05% |
+5,911,000
| New | +$180M |
|
|
GRFS
240
Grifois
GRFS
$5.4B
| $173M | 0.05% |
7,900,343
-1,195,476
| -13% | -$24.8M |
|
241
Xcel Energy
XEL
$49.1B
| $171M | 0.05% |
3,615,000
| – | – |
|
242
Baker Hughes
BKR
$63.8B
| $169M | 0.05% |
+4,602,000
| New | +$163M |
|
243
Domino's
DPZ
$11.7B
| $168M | 0.05% |
845,500
-211,300
| -20% | -$41.1M |
|
244
CME Group
CME
$94.3B
| $166M | 0.05% |
1,227,000
| – | – |
|
245
SM Energy
SM
$7.71B
| $161M | 0.05% |
9,070,141
+2,142,235
| +31% | +$33.5M |
|
246
Five Below
FIVE
$13.2B
| $160M | 0.05% |
2,919,622
+149,402
| +5% | +$7.31M |
|
247
D.R. Horton
DHI
$40.8B
| $160M | 0.05% |
4,000,000
| – | – |
|
|
WFT
248
DELISTED
Weatherford International plc
WFT
| $159M | 0.05% |
34,818,617
-1,009,000
| -3% | -$4.17M |
|
|
ACIA
249
DELISTED
Acacia Communications Inc
ACIA
| $158M | 0.05% |
3,359,162
+7,557
| +0.2% | +$337K |
|
250
Kimco Realty
KIM
$16.2B
| $156M | 0.05% |
+8,000,000
| New | +$157M |
|
Similar funds
Capital Research Global Investors's Q3 2017 Portfolio in Review
As of Q3 2017, Capital Research Global Investors held 463 positions worth $331B, up 3.7% from $319B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2017 filing shows 32 new, 132 increased, 144 reduced and 31 closed positions. Its largest new stake was British American Tobacco: 15,546,114 shares worth $971M. The largest sale was Oracle, an estimated $2.61B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2017 buy was British American Tobacco: 15,546,114 shares worth $971M.
- Capital Research Global Investors added most to Vale in Q3 2017, an estimated $1.61B increase.
- Capital Research Global Investors's biggest Q3 2017 reduction was Oracle, cutting an estimated $2.61B.
- Capital Research Global Investors fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.97B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $331B portfolio in Q3 2017.
- Capital Research Global Investors opened 32 new positions and closed 31 in Q3 2017.
- Capital Research Global Investors's portfolio value rose 3.7% quarter-over-quarter to $331B.
Based on Capital Research Global Investors's 13F filing for Q3 2017, filed 14 Nov 2017.